Achieving Long-Term Implantable Drug Delivery

In another interview from the Road to 50 States, Rob Sterling and Tony Listro of Foster Delivery Science talk to Nigel about the next big thing in pharma and why the company is the leader and the expert in long-term implantable drug delivery.

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Foster Delivery Science

Founded in 1989, Foster Corporation serves the specialty polymer requirements of newly emerging medical device companies. By leveraging its expertise in melt extrusion to serve the unique needs of the pharmaceutical industry, the subsidiary Foster Delivery Science was founded over ten years ago. Since its inception, this subsidiary has become a leader in custom blending and extrusion of biomedical polymers additives. Headquartered in Putnam, Connecticut, Foster Delivery Science services include the explanation of the hot melt extrusion process, polymers and excipients and application segments.

Q: